Page 21 - Read Online
P. 21

Turner et al.                                                                                                                                                                           LPS preconditioning neuroprotective

           FJB staining has been associated with motor deficits   microglial changes. LPS can promote the infiltration
           following TBI. [32]  In a future study, we plan to look at   of macrophages into the brain, which helps resolve
           the role of LPS preconditioning in preventing motor   the microglia response after diffuse traumatic
           deficits following TBI.                            axonal injury. [35]  Microglia is broadly grouped into
                                                              pro-inflammatory M1 microglia and pro-survival
           Reactive  astrocytes  can  inhibit  axonal  regrowth   anti-inflammatory M2 microglia. [36]   The balance of
           after an axon is severed. [33]  OSM activity increases   M1  to M2 microglia is  tightly controlled  following
           in demyelinated  areas, leading  to  an  upregulation   injury. [37]  M1 microglia can exacerbate axonal injury,
           of OSMR.  This upregulation indicates a loss       thereby limiting functional recovery. We showed
           of  detrimental  connectivity, [22]   while  decreased   that LPS preconditioning selectively inhibited
           OSMR indicates preservation of myelin integrity    the M1 response. LPS caused an acute increase
           and axonal tracts. Our findings show that LPS      in pro-inflammatory markers, which may signal
           preconditioning significantly reduces OSMR levels   peripheral macrophages to cross brain vasculature
           [Figure 7]. Interestingly, GFAP expression was also   by chemotaxis. Peripheral macrophages alter the
           downregulated, which may reflect an interaction    inflammatory mileu of the brain while attenuating
           between LPS and toll like receptor 4 (TLR4). Low-  microglial activity. [38]  In contrast, M2 microglia
           dose LPS administration can stimulate  TLR4,       are  largely  unaffected  due  to  the  earlier  peak  of
           which activates signaling cascades to suppress     activation after injury, which we have shown using
           innate immunity and astrocyte activation.  These   non-differentiated  IBA-1  imaging. [39]   The  brain
           cell-signaling events permit axonal regeneration   establishes functional recovery by shifting the
           without the threat of glial scar formation. [34]  As long   balance away from M1 microglia.
           as  myelin  integrity  is  maintained,  neurons  can
           re-innervate most of their lost connections.  The   LPS has been associated with inflammation.
           clinical use of LPS preconditioning is obviously   Suppressing inflammation limits the effect of LPS on
           limited because injury cannot be predicted, but    human physiology. [40]  LPS increases tissue necrosis
           targeting  TLR4 pharmacologically might represent   factor α, interleukin 6, and interleukin 1 expression
           a  reasonable  strategy.  Further  work  is  needed  to   [Figure 6]. [41]  LPS preconditioning reduces neuronal
           determine the exact interactions between low-dose   loss and microglia activation in other injury models,
           LPS administration and TLR4.                       such as global hypoxia. [42]  In the present study, LPS
                                                              preconditioning also significantly reduced neuronal
           In addition to effects on astrocytosis, LPS        degeneration following diffuse axonal injury.
           preconditioning has also been associated with      Chronic  LPS-mediated  inflammation  is  detrimental
































           Figure 7: Hypothetical schematic showing the mechanism of LPS action. LPS: lipopolysaccharide; TBI: traumatic brain injuries; OSMR:
           oncostatin M receptor; TLR4: toll like receptor 4
                          Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ January 20, 2017              13
   16   17   18   19   20   21   22   23   24   25   26